Literature DB >> 7918299

Fundus albipunctatus-like lesions in juvenile retinoschisis.

M J van Schooneveld1, Y Miyake.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7918299      PMCID： PMC504898          DOI： 10.1136/bjo.78.8.659

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Unusual manifestations of X-linked retinoschisis.

Authors:  C M Greven; R J Moreno; W Tasman
Journal:  Trans Am Ophthalmol Soc       Date:  1990

2.  [X-chromosomal congenital retinoschisis--its fundus polymorphism and visual function (author's transl)].

Authors:  Y Miyake; S Miyake; K Yanagida; T Kanda
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1981-02

3.  Fundus albipunctatus associated with cone dystrophy.

Authors:  Y Miyake; N Shiroyama; S Sugita; M Horiguchi; K Yagasaki
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

4.  Long-term follow-up of the physiologic abnormalities and fundus changes in fundus albipunctatus.

Authors:  M F Marmor
Journal:  Ophthalmology       Date:  1990-03       Impact factor: 12.079

5.  Congenital hereditary (juvenile X-linked) retinoschisis. Histopathologic and ultrastructural findings in three eyes.

Authors:  G P Condon; S Brownstein; N S Wang; J A Kearns; C C Ewing
Journal:  Arch Ophthalmol       Date:  1986-04
  5 in total
  3 in total

Review 1.  X linked retinoschisis.

Authors:  N D George; J R Yates; A T Moore
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

2.  Novel phenotypic and genotypic findings in X-linked retinoschisis.

Authors:  Stephen H Tsang; Veronika Vaclavik; Alan C Bird; Anthony G Robson; Graham E Holder
Journal:  Arch Ophthalmol       Date:  2007-02

3.  Clinical and genetic findings in Hungarian patients with X-linked juvenile retinoschisis.

Authors:  B Lesch; V Szabó; M Kánya; G M Somfai; R Vámos; B Varsányi; Zs Pámer; K Knézy; Gy Salacz; M Janáky; M Ferencz; J Hargitai; A Papp; A Farkas
Journal:  Mol Vis       Date:  2008-12-12       Impact factor: 2.367
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.